Stewartsville, NJ, United States of America

Beverly C Langevin

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Tvardi Therapeutics, Inc., Aventis Pharmaceuticals Inc.. Active years: 2010-2024.

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Beverly C Langevin: Innovator in Therapeutic Compounds

Introduction

Beverly C Langevin is a notable inventor based in Stewartsville, NJ (US). She has made significant contributions to the field of therapeutic compounds, holding a total of 4 patents. Her work focuses on innovative formulations that have the potential to treat serious health conditions.

Latest Patents

Langevin's latest patents include compositions and formulations that comprise a compound of Formula (I). These compositions are designed to include an emulsifier, a solubilizer, a polyethylene glycol, a surfactant, and an antioxidant. In specific instances, these formulations are useful for the treatment of fibrosis, cancer, and chronic inflammation. The innovative nature of her work highlights the importance of developing effective therapeutic solutions.

Career Highlights

Throughout her career, Langevin has worked with prominent companies such as Tvardi Therapeutics, Inc. and Aventis Pharmaceuticals Inc. Her experience in these organizations has allowed her to refine her expertise in the development of therapeutic compounds.

Collaborations

Langevin has collaborated with talented individuals in her field, including Imran Alibhai and Sofia De Achaval. These partnerships have contributed to her success and the advancement of her innovative projects.

Conclusion

Beverly C Langevin is a distinguished inventor whose work in therapeutic compounds has the potential to make a significant impact on healthcare. Her innovative formulations and collaborations reflect her commitment to advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…